|
|
The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.
For pediatric patients, intravenous fluids are the most commonly cited products involved in medication errors that are reported to the USP.
For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.
All patients with hyperparathyroidism will develop osteoporosis. The parathyroid glands maintain blood calcium within the normal range. All patients with this disease will continue to lose calcium from their bones every day, and there is no way to prevent the development of osteoporosis as a result.
Multiple experimental evidences have confirmed that at the molecular level, cancer is caused by lesions in cellular DNA.